Volume 22 (2023)
Volume 21 (2022)
Volume 20 (2021)
Volume 19 (2020)
Volume 18 (2019)
Volume 17 (2018)
Volume 16 (2017)
Volume 15 (2016)
Volume 14 (2015)
Volume 13 (2014)
Volume 12 (2013)
Volume 11 (2012)
Volume 10 (2011)
Adding erythropoietin to intravenous methylprednisolone in acute treatment of attacks of neuromyelitis optica spectrum disorders: A randomized controlled trial

Maryam Shafaei; Fereshteh Ghadiri; Amirreza Azimi; Abdorreza Naser Moghadasi; Mahdi Hakiminezhad; Mohammad Ali Sahraian

Volume 21, Issue 4 , October 2022, , Pages 201-205

  Background: Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease of the central nervous system (CNS) that prompts immediate potent treatment. Delaying treatment could leave debilitating sequelae. As erythropoietin (EPO) has shown neuroprotective effects, we studied the effects of adding ...  Read More

The association between body mass index, demographic and clinical characteristics with cognitive performance in patients with neuromyelitis optica spectrum disorder

Nasim Rezaeimanesh; Roghayyeh Saeedi; Mohammad Ali Sahraian; Fereshteh Ghadiri; Abdorreza Naser Moghadasi

Volume 21, Issue 2 , April 2022, , Pages 74-82


  Background: Cognitive dysfunction is one of the problems that patients with neuromyelitis optica spectrum disorder (NMOSD) suffer from. We aimed to assess the association between demographic and clinical features as well as body mass index (BMI) and cognitive function in patients with NMOSD.Methods: ...  Read More

Simultaneous screening for antibodies to myelin oligodendrocyte glycoprotein and aquaporin-4 in patients with optic neuritis using cell-based assay

Durgadevi Parthasarathy; Kulandai Lily Therese; Selvakumar Ambika; Selvi Krishnan; Durga Priyadarshini Santhakumar

Volume 21, Issue 1 , January 2022, , Pages 29-34


  Background: This study was aimed to test simultaneous detection of antibodies to myelin oligodendrocyte glycoprotein (MOG)/aquaporin‑4 (AQP4) in serum samples of patients with clinically-diagnosed optic neuritis (ON), by fixed cell-based immunofluorescence assay (CBIFA).Methods: The study involved ...  Read More

Whole grains and legumes consumption in association with neuromyelitis optica spectrum disorder odds

Nasim Rezaeimanesh; Shadi Ariyanfar; Mohammad Ali Sahraian; Abdorreza Naser Moghadasi; Zeinab Ghorbani; Soodeh Razegh-Jahromi

Volume 20, Issue 3 , July 2021, , Pages 131-138


  Background: The environmental risk factors of neuromyelitis optica spectrum disorder (NMOSD) are not fully specified.Regarding the evidence on the possible protective effects of whole grains and legumes against inflammatory disorders, we examined the association between the mentioned dietary components ...  Read More

Prevalence of coronavirus disease 2019 in patients with neuromyelitis optica in Isfahan, Iran, and a review on recent reports and literature

Masoud Etemadifar; Mehri Salari; Zahra Aminzade; Sara Ebrahimi; Sepand Tehrani-Fateh

Volume 20, Issue 3 , July 2021, , Pages 139-145


  Background: Despite many studies, it is still unclear how patients with neuromyelitis optica spectrum disorder (NMOSD) would respond to coronavirus disease 2019 (COVID-19). We conducted a research on prevalence of COVID-19 in patients with NMOSD in Isfahan, Iran. We have also reviewed the recent publications ...  Read More

Clinical outcomes of transverse myelitis with myelin oligodendrocyte glycoprotein antibody versus negative cases among adults in Isfahan, Iran: A comparative study

Masoud Etemadifar; Ahmad Chitsaz; Sahebeh Rajabkhah; Hossein Tavakoli; Arezoo Shafieyoun; Pegah Noorshargh; Mahdieh Afzali

Volume 19, Issue 4 , October 2020, , Pages 173-179


  Background: The aim of this study was to evaluate the status of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with transverse myelitis (TM) and compare the clinical and imaging characteristics of MOG immunoglobulin G (IgG)-positive with negative cases. Methods: This cohort study ...  Read More